PFE(Pfizer Inc.) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $81.29B | $101.17B | $59.55B | $63.63B | $62.58B |
| 毛利润 | $50.47B | $66.83B | $34.60B | $45.78B | $46.51B |
| 营业利润 | — | — | — | — | — |
| 净利润 | $21.98B | $31.37B | $2.12B | $8.03B | $7.77B |
| 经营现金流 | $32.58B | $29.27B | $8.70B | $12.74B | $11.70B |
| 自由现金流 | $29.87B | $26.03B | $4.79B | $9.84B | $9.07B |
| 摊薄每股收益 | $3.85 | $5.47 | $0.37 | $1.41 | $1.36 |